AQP4 tag SNPs in patients with intracerebral hemorrhage in Greek and Polish population.


Journal

Neuroscience letters
ISSN: 1872-7972
Titre abrégé: Neurosci Lett
Pays: Ireland
ID NLM: 7600130

Informations de publication

Date de publication:
23 03 2019
Historique:
received: 02 07 2018
revised: 09 12 2018
accepted: 18 12 2018
pubmed: 24 12 2018
medline: 3 9 2019
entrez: 23 12 2018
Statut: ppublish

Résumé

A relatively small number of genetic variants are implicated to pathophysiology of intracerebral hemorrhage (ICH). Aquaporin-4 (AQP4) has been reported to be implicated in the pathophysiological processes of ICH development. To examine the role of AQP4 gene region polymorphisms on the ICH risk. A total of 250 Greek and 193 Polish patients with primary ICH and 250 and 322 respective controls were enrolled, forming two independent cohorts in order to validate any significant effect. With logistic regression analyses, 7 AQP4 tag single nucleotide polymorphisms (SNPs) were examined for association with ICH risk, lobar/non-lobar ICH risk, and 6-month disability after ICH. Cox regression analysis was applied in order to the effect of AQP4 SNPs on ICH age of onset be tested. Correction for multiple comparisons was applied. Multivariate logistic regression analysis showed that rs3875089 in the Greek cohort and rs3763043, rs335931 in the Polish cohort had a significant influence on the risk of ICH, lobar and non-lobar ICH. Regarding the age of onset, rs3875089 in the Greek cohort and rs3763043, rs11661256 in the Polish cohort were found to significantly alter the age of onset of ICH and its subtypes. However, all of the above associations did not survive the Bonferroni correction (p-value >0.007). Finally, AQP4 tag SNPs were not found to have any significant effect on long-term disability after ICH. In conclusion, the present study provides an indication that AQP4 gene variants may affect susceptibility to primary ICH and may influence the ICH age of onset.

Identifiants

pubmed: 30578930
pii: S0304-3940(18)30870-X
doi: 10.1016/j.neulet.2018.12.025
pii:
doi:

Substances chimiques

AQP4 protein, human 0
Aquaporin 4 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-161

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Efthimios Dardiotis (E)

Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece. Electronic address: edar@med.uth.gr.

Vasileios Siokas (V)

Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece.

Chrysa Marogianni (C)

Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece.

Athina-Maria Aloizou (AM)

Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece.

Maria Sokratous (M)

Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece.

Konstantinos Paterakis (K)

Department of Neurosurgery, University of Thessaly, University Hospital of Larissa, Larissa, Greece.

Maria Dardioti (M)

Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece.

Savas Grigoriadis (S)

Second Department of Neurosurgery, Hippokration University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Alexandros Brotis (A)

Department of Neurosurgery, University of Thessaly, University Hospital of Larissa, Larissa, Greece.

Eftychia Kapsalaki (E)

Department of Radiology, University of Thessaly, School of Medicine, Larissa, Greece.

Kostas Fountas (K)

Department of Neurosurgery, University of Thessaly, University Hospital of Larissa, Larissa, Greece.

Jeremiasz Jagiella (J)

Department of Neurology, Medical College Jagiellonian University, Krakow, Poland.

Georgios M Hadjigeorgiou (GM)

Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece; Department of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH